A well-designed cross-sectional study with biomarker-confirmed early AD and matched controls, demonstrating a mechanistic link between motor cortical hyperexcitability and cognitive impairment, but limited by cross-sectional design and lack of longitudinal or clinical outcome validation.
Twin study establishing heritability and genetic correlations among Alzheimer's plasma biomarkers in a cognitively normal cohort, providing mechanistic insight but using surrogate biomarkers rather than clinical outcomes.
Cross-sectional analysis of biomarker interactions in a single racial group with surrogate cognitive outcomes; lacks independent replication and mechanistic validation needed to establish clinical relevance.
Post-mortem observational study with transcriptomic analysis identifies associations between infection status and gene expression patterns in AD brain tissue, but lacks experimental validation, longitudinal data, or causal evidence to support clinical intervention.
A single-centre prospective cohort study with well-defined neuropsychological criteria identifying a discrete clinical phenotype (decreased awareness of cognitive decline) associated with multimodal AD biomarkers in cognitively unimpaired individuals; promising but requires replication and validation in independent populations.
An environmental scan of existing data collection practices across Canadian cohorts; descriptive and comparative rather than hypothesis-testing, with no intervention or outcome measurement beyond cataloging current methods.
Observational network analysis identifying associations between blood inflammation markers and aging/AD biomarkers, but without causal inference, comparator group, or effect sizes to support clinical decision-making.